Article
Rapid resistance profiling of SARS-CoV-2 protease inhibitors - npj Antimicrobials and Resistance
Rating:
0.0
Views:
46
Likes:
1
Library:
1
Resistance to nirmatrelvir (Paxlovid) has been shown by multiple groups and may already exist in clinical SARS-CoV-2 isolates. Here a robust cell-based assay is used to determine the relative potencies of nirmatrelvir, ensitrelvir, and FB2001 against a panel of SARS-CoV-2 main protease (Mpro) variants.
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value